XSHE
300138
Market cap840mUSD
Dec 05, Last price
12.30CNY
1D
1.65%
1Q
-9.16%
Jan 2017
32.24%
IPO
53.35%
Name
Chenguang Biotech Group Co Ltd
Chart & Performance
P/E
63.18
P/S
0.85
EPS
0.19
Div Yield, %
1.06%
Shrs. gr., 5y
0.14%
Rev. gr., 5y
16.46%
Revenues
6.99b
+1.79%
Net income
94m
-80.39%
CFO
-223m
L-56.39%
Dividend
Jun 13, 20240.13 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil; lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts; and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, cottonseed oil, natural lutein, and dephenolized cottonseed protein products. Its products are primarily used in food, cosmetics, baking, beverages, health care, and feed industries. The company operates in Europe; the Americas; Australia; China, Russia, Japan, Korea, and other countries in Asia; and Africa. ChenGuang Biotech Group Co., Ltd. was incorporated in 2000 and is based in Quzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||